| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,775 |
1,503 |
$41K |
| 99401 |
|
1,073 |
523 |
$7K |
| 90834 |
Psychotherapy, 45 minutes with patient |
209 |
123 |
$2K |
| 80305 |
|
238 |
200 |
$1K |
| 64493 |
|
23 |
15 |
$462.98 |
| G3002 |
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) |
179 |
99 |
$420.27 |
| 96136 |
|
34 |
25 |
$315.54 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52 |
26 |
$287.60 |
| 64494 |
|
23 |
15 |
$161.53 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
35 |
26 |
$141.78 |
| G3003 |
Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) |
78 |
54 |
$92.82 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
41 |
26 |
$51.87 |
| 99408 |
|
13 |
12 |
$39.68 |
| 99072 |
|
750 |
428 |
$29.21 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
23 |
12 |
$10.08 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,411 |
739 |
$0.32 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
1,193 |
627 |
$0.27 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
616 |
290 |
$0.12 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
578 |
270 |
$0.08 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
578 |
270 |
$0.08 |
| G9561 |
Patients prescribed opiates for longer than six weeks |
578 |
270 |
$0.08 |
| G9583 |
Patients prescribed opiates for longer than six weeks |
578 |
270 |
$0.08 |
| G9577 |
Patients prescribed opiates for longer than six weeks |
160 |
84 |
$0.05 |
| 3288F |
|
1,194 |
627 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
278 |
140 |
$0.00 |
| 1006F |
|
278 |
140 |
$0.00 |